UK has no plans to buy rapid COVID-19 test favoured by US and WHOThe US and some of the world’s poorest countries may get a low-cost and rapid COVID-19 test ahead Share XUK has no plans to buy rapid COVID-19 test favoured by US and WHOhttps://pharmaphorum.com/news/uk-has-no-plans-to-buy-rapid-covid-19-test-favoured-by-us-and-who/
AZ’s COVID-19 vaccine trial pause a ‘wake-up call’ – WHOAstraZeneca’s pause of its COVID-19 vaccine trial is a “wake-up call” demonstrating the challenges of the development process, Share XAZ’s COVID-19 vaccine trial pause a ‘wake-up call’ – WHOhttps://pharmaphorum.com/news/azs-covid-19-vaccine-trial-pause-a-wake-up-call-who/
WHO restarts trial of COVID-19 drug hydroxychloroquineThe World Health Organization has restarted its trial of COVID-19 drug hydroxychloroquine, the malaria drug favoured by president Donald Trump, after a temporary Share XWHO restarts trial of COVID-19 drug hydroxychloroquinehttps://pharmaphorum.com/news/who-restarts-trial-of-covid-19-drug-hydroxychloroquine/
Bringing gene therapies to marketDoug Danison, vice-president, head of access, value and evidence strategy at bluebird bio, a gene therapy company, looks Share XBringing gene therapies to markethttps://deep-dive.pharmaphorum.com/magazine/access-and-commercialisation/bluebird-bio-gene-therapies-market/
WHO releases first guidelines on digital healthThe World Health Organization (WHO) has released new recommendations on ways that countries can use digital health technology Share XWHO releases first guidelines on digital healthhttps://pharmaphorum.com/news/who-releases-first-guidelines-on-digital-health/
